Abstract
As stem cell therapies advance, rethinking of medical device engineering provides promise for treatment options in clinical applications. In the past decades, cell transplantation has been an approach for many regenerative therapies. To date, however, limited human donor supply has hampered the transplantation of human organs and mature donor tissues for an increasing number of patients worldwide, particularly those with liver and pancreatic diseases. This chapter explores the use of stem cells as an alternative to implantation of mature cells and discusses the development of stem cell therapies that may promote organ regeneration, or delivery of endocrine products in vivo, and their challenges for the use in clinical applications. Aspects of stem cell differentiation strategies, microenvironmental factors, and cellular immunity are addressed. A second limitation to cellular transplantation has been the need for chronic immunosuppression. As an alternative to clinical immunosuppression, designs and materials for cellular encapsulation, intended to avoid rejection by the immune system and to control growth of cellular implants, have been developed. Liver disease is chosen to show examples of stem cell micro-encapsulation approaches in research and therapy. Secondly, a stem cell macro-encapsulation device is used as an example for a bio-artificial pancreas as a possible therapeutic approach for diabetes mellitus. The focus of this chapter is on the synergy between stem cell therapy and medical device engineering as a multi-disciplinary approach in the field of bioengineering, which may eventually provide new options for treatment of human disease.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- ECM:
-
Extra Cellular Matrix
- hESC:
-
Human Embryonic Stem Cell
- iPSC:
-
Induced Pluripotent Stem Cell
- LPC:
-
Liver Progenitor Cell
- MSC:
-
Mesenchymal Stem Cell
- PPC:
-
Pancreatic Progenitor Cell
References
Everhart, J. E., & Ruhl, C. E. (2009). Burden of digestive diseases in the United States part III: Liver, biliary tract, and pancreas. Gastroenterology, 136(4), 1134–1144.
Yadav, D., & Lowenfels, A. B. (2013). The epidemiology of pancreatitis and pancreatic cancer. Gastroenterology, 144(6), 1252–1261.
Congress, I. L. (2016). Fast facts about liver disease—The international Liver Congress 2016, April 13–17. The Home of Hepatology. http://2016.ilc-congress.eu/wp-content/uploads/2016/04/Liver-disease-backgrounder.pdf.
Blachier, M., Leleu, H., Peck-Radosavljevic, M., Valla, D. C., & Roudot-Thoraval, F. (2013). The burden of liver disease in Europe: A review of available epidemiological data. Journal of hepatology, 58(3), 593–608.
Lévy, P., Domínguez-Muñoz, E., Imrie, C., Löhr, M., & Maisonneuve, P. (2014) Epidemiology of chronic pancreatitis: burden of the disease and consequences. United European Gastroenterology Journal, 2(5), 345–354.
Peery, A. F., Crockett, S. D., Barritt, A. S., Dellon, E. S., Eluri, S., Gangarosa, L. M., … Schmidt, M. (2015). Burden of Gastrointestinal, Liver, and Pancreatic Diseases in the United States. Gastroenterology, 149(7), 1731–1741 e3.
Zaret, K. S. (2008). Genetic programming of liver and pancreas progenitors: Lessons for stem-cell differentiation. Nature Reviews Genetics, 9(5), 329–340.
Rous, P., & Murphy, J. B. (1912). The histological signs of resistance to a transmissible sarcoma of the fowl. Journal of Experimental Medicine, 15(3), 270–286.
Bisceglie, V. (1933). Uber die antineoplastische Immunitat: (I) Heterologe Einpflanzung von Tumoren in Huhnerembryonen. Zeitschrift für Krebsforschung, 40, 122–140.
Bisceglie, V. (1933). Uber die antineoplastische Immunität; (II) Die Wachstumfahigkeit von heterologen Geschwulsten in erwachsenen Tieren nach Einpflanzung in Kollodiumsackchen. Zeitschrift für Krebsforschung, 40, 141–158.
Chang, T. M. (1964). Semipermeable microcapsules. Science, 146(3643), 524–525.
Federlin, K., & Raptis, S. (2001). Ernst F. Pfeiffer: His impact on diabetes research and treatment over the last 45 years. Experimental and Clinical Endocrinology & Diabetes, 109(2), S83–S85.
Bowen, K. M., Andrus, L., & Lafferty, K. J. (1980). Successful allotransplantation of mouse pancreatic islets to nonimmunosuppressed recipients. Diabetes, 29(1), 98–104.
Lafferty, K. J., Andrus, L., & Prowse, S. J. (1980). Role of lymphokine and antigen in the control of specific T cell responses. Immunological Reviews, 51, 279–314.
Chick, W. L., Perna, J. J., Lauris, V., Low, D., Galletti, P. M., Panol, G., et al. (1977). Artificial pancreas using living beta cells: Effects on glucose homeostasis in diabetic rats. Science, 197(4305), 4780–4782.
Lim, F., & Sun, A. M. (1980). Microencapsulated islets as bioartificial endocrine pancreas. Science, 210(4472), 908–910.
Cima, L. G., Vacanti, J. P., Vacanti, C., Ingber, D., Mooney, D., & Langer, R. (1991). Tissue engineering by cell transplantation using degradable polymer substrates. Journal of Biomechanical Engineering, 113(2), 143–151.
https://ki.mit.edu/people/faculty/langer. Robert S. Langer. 2017.
Krishnan, R., Alexander, M., Robles, L., Foster III, C. E., & Lakey, J. R. (2014). Islet and stem cell encapsulation for clinical transplantation. The Review of Diabetic Studies, 11(1), 84–101.
Soon-Shiong, P., Heintz, R. E., Merideth, N., Yao, Q. X., Yao, Z., Zheng, T. I. A. N. L. I., … Mendez, R. (1994). Insulin independence in a type 1 diabetic patient after encapsulated islet transplantation. Lancet, 343(8903), 950–951.
Calafiore, R., Basta, G., Luca, G., Lemmi, A., Montanucci, M. P., Calabrese, G., … Brunetti, P. (2006). Microencapsulated pancreatic islet allografts into nonimmunosuppressed patients with type 1 diabetes: first two cases. Diabetes Care, 29(1), 137–138.
Löhr, M., Bago, Z. T., Bergmeister, H., Ceijna, M., Freund, M., Gelbmann, W., … Henninger, W. (1999). Cell therapy using microencapsulated 293 cells transfected with a gene construct expressing CYP2B1, an ifosfamide converting enzyme, instilled intra-arterially in patients with advanced-stage pancreatic carcinoma: a phase I/II study. Journal of Molecular Medicine, 77(4), 393–398.
Löhr, M., Hoffmeyer, A., Kröger, J. C., Freund, M., Hain, J., Holle, A., … Nizze, H. (2001). Microencapsulated cell-mediated treatment of inoperable pancreatic carcinoma. Lancet, 357(9268), 1591–1592.
Löhr, M., Kroger, J. C., Hoffmeyer, A., Freund, M., Hain, J., Holle, A., … Saller, R. (2003). Safety, feasibility and clinical benefit of localized chemotherapy using microencapsulated cells for inoperable pancreatic carcinoma in a phase I/II trial. Cancer Therapy, 1, 121–131.
Pelegrin, M., Marin, M., Noel, D., Del Rio, M., Saller, R., Stange, J., … Piechaczyk, M. (1998). Systemic long-term delivery of antibodies in immunocompetent animals using cellulose sulphate capsules containing antibody-producing cells. Gene Therapy, 5(6), 828–834.
Hartgerink, J. D., Beniash, E., & Stupp, S. I. (2001). Self-assembly and mineralization of peptide-amphiphile nanofibers. Science, 294(5547), 1684–1688.
Kobayashi, T., Aomatsu, Y., Iwata, H., Kin, T., Kanehiro, H., Hisanaga, M., … Nakajima, Y. (2003). Indefinite islet protection from autoimmune destruction in nonobese diabetic mice by agarose microencapsulation without immunosuppression. Transplantation, 75(5), 619–625.
Haque, T., Chen, H., Ouyang, W., Martoni, C., Lawuyi, B., Urbanska, A. M., & Prakash, S. (2005). In vitro study of alginate-chitosan microcapsules: an alternative to liver cell transplants for the treatment of liver failure. Biotechnology Letters, 27(5), 317–322.
Young, S., Wong, M., Tabata, Y., & Mikos, A. G. (2005). Gelatin as a delivery vehicle for the controlled release of bioactive molecules. Journal of Controlled Release, 109(1–3), 256–274.
Dong, H., Fahmy, T. M., Metcalfe, S. M., Morton, S. L., Dong, X., Inverardi, L., … Wang, H. (2012). Immuno-isolation of pancreatic islet allografts using pegylated nanotherapy leads to long-term normoglycemia in full MHC mismatch recipient mice. PLoS One, 7(12), e50265.
Kim, A. R., Hwang, J. H., Kim, H. M., Kim, H. N., Song, J. E., Yang, Y. I., … Khang, G. (2013). Reduction of inflammatory reaction in the use of purified alginate microcapsules. Journal of Biomaterials Science, Polymer Edition, 24(9), 1084–1098.
Hueck, I. S., Haas, M., Finones, R., Frimodig, J., & Gough, D. A. (2011). The potential of selectively cultured adult stem cells re-implanted in tissues. In Artmann (Ed.), Stem cell engineering: Principles and applications (pp. 79–117). Berlin: Springer.
Seale, N. M., & Varghese, S. (2016). Biomaterials for pluripotent stem cell engineering: from fate determination to vascularization. Journal of Materials Chemistry B, 4(20), 3454–3463.
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell, 131(5), 861–872.
Aasen, T., Raya, A., Barrero, M. J., Garreta, E., Consiglio, A., Gonzalez, F., … Edel, M. (2008). Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nature Biotechnology, 26(11), 1276–1284.
Loh, Y. H., Hartung, O., Li, H., Guo, C., Sahalie, J. M., Manos, P. D., … Lensch, M. W. (2010). Reprogramming of T cells from human peripheral blood. Cell Stem Cell, 7(1), 15–19.
Zhou, T., Benda, C., Dunzinger, S., Huang, Y., Ho, J. C., Yang, J., … Bao, X. (2012). Generation of human induced pluripotent stem cells from urine samples. Nature Protocols, 7(12), 2080–2089.
Selvaraj, V., Plane, J. M., Williams, A. J., & Deng, W. (2010). Switching cell fate: the remarkable rise of induced pluripotent stem cells and lineage reprogramming technologies. Trends in Biotechnology, 28(4), 214–223.
Liu, H., Ye, Z., Kim, Y., Sharkis, S., & Jang, Y. Y. (2010). Generation of endoderm-derived human induced pluripotent stem cells from primary hepatocytes. Hepatology, 51(5), 1810–1819.
Sullivan, G. J., Hay, D. C., Park, I. H., Fletcher, J., Hannoun, Z., Payne, C. M., … Wang, G. (2010). Generation of functional human hepatic endoderm from human induced pluripotent stem cells. Hepatology, 51(1), 329–335.
Wu, S., Xu, H., Chen, B., Wen, Y., Ikusika, O. M., Ocker, A., … Ildstad, S. T. (2011). Sensitized recipients exhibit accelerated but not hyperacute rejection of vascularized composite tissue allografts. Transplantation, 92(6), 627–633.
Yamanaka, S. (2012). Induced pluripotent stem cells: Past, present, and future. Cell Stem Cell, 10(6), 678–684.
Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D., … Marshak, D. R. (1999). Multilineage potential of adult human mesenchymal stem cells. Science, 284(5411), 143–147.
Kadam, S., Muthyala, S., Nair, P., & Bhonde, R. (2010). Human placenta-derived mesenchymal stem cells and islet-like cell clusters generated from these cells as a novel source for stem cell therapy in diabetes. The Review of Diabetic Studies, 7(2), 168–182.
Ngoc, P. K., Van Phuc, P., Nhung, T. H., Thuy, D. T., & Nguyet, N. T. M. (2011). Improving the efficacy of type 1 diabetes therapy by transplantation of immunoisolated insulin-producing cells. Human Cell, 24(2), 86–95.
Goren, A., Dahan, N., Goren, E., Baruch, L., & Machluf, M. (2010). Encapsulated human mesenchymal stem cells: a unique hypoimmunogenic platform for long-term cellular therapy. FASEB J, 24(1), 22–31.
Wilson, J. L., & McDevitt, T. C. (2013). Stem cell microencapsulation for phenotypic control, bioprocessing, and transplantation. Biotechnology and Bioengineering, 110(3), 667–682.
Baraniak, P. R., & McDevitt, T. C. (2010). Stem cell paracrine actions and tissue regeneration. Regenerative Medicine, 5(1), 121–143.
Orive, G., Gascón, A. R., Hernández, R. M., Igartua, M., & Pedraz, J. L. (2003). Cell microencapsulation technology for biomedical purposes: Novel insights and challenges. Trends in Pharmacological Sciences, 24(5), 207–210.
Hunkeler, D. (2001). Allo transplants xeno: As bioartificial organs move to the clinic. Introduction. Annals of the New York Academy of Sciences, 944, 1–6.
Kang, H. K., Wang, S., Dangi, A., Zhang, X., Singh, A., Zhang, L., … Thorp, E. B. (2017). Differential role of B cells and IL-17 versus IFN-gamma during early and late rejection of pig islet xenografts in mice. Transplantation.
Dufrane, D., & Gianello, P. (2012). Pig islet for xenotransplantation in human: Structural and physiological compatibility for human clinical application. Transplantation Reviews, 26(3), 183–188.
Dufrane, D., & Gianello, P. (2012). Macro- or microencapsulation of pig islets to cure type 1 diabetes. World Journal of Gastroenterology, 18(47), 6885–6893.
Zhu, H. T., Lu, L., Liu, X. Y., Yu, L., Lyu, Y., & Wang, B. (2015). Treatment of diabetes with encapsulated pig islets: An update on current developments. Journal of Zhejiang University-Science B, 16(5), 329–343.
Gunzburg, W. H., & Salmons, B. (2000). Xenotransplantation: Is the risk of viral infection as great as we thought? Molecular Medicine Today, 6(5), 199–208.
Bowie, K. M., & Chang, P. L. (1998). Development of engineered cells for implantation in gene therapy. Advanced Drug Delivery Reviews, 33(1–2), 31–43.
Uludag, H., De Vos, P., & Tresco, P. A. (2000). Technology of mammalian cell encapsulation. Advanced Drug Delivery Reviews, 42(1–2), 29–64.
Sakai, S., Mu, C., Kawabata, K., Hashimoto, I., & Kawakami, K. (2006). Biocompatibility of subsieve-size capsules versus conventional-size microcapsules. Journal of Biomedical Materials Research Part A, 78(2), 394–398.
Fang, S., & MAO, L. (2007). Differentiation of embryoid-body cells derived from embryonic stem cells into hepatocytes in alginate microbeads in vitro. Acta Pharmacologica Sinica, 28(12), 1924–1930.
Orive, G., Hernández, R. M., Gascón, A. R., Calafiore, R., Chang, T. M. S., de Vos, P., … Pedraz, J. L. (2004). History, challenges and perspectives of cell microencapsulation. Trends in Biotechnology, 22(2), 87–92.
Rabanel, J. M., Banquy, X., Zouaoui, H., Mokhtar, M., & Hildgen, P. (2009). Progress technology in microencapsulation methods for cell therapy. Biotechnology Progress, 25(4), 946–963.
Kidd, K. R., Nagle, R. B., & Williams, S. K. (2002). Angiogenesis and neovascularization associated with extracellular matrix-modified porous implants. Journal of Biomedical Materials Research, 59(2), 366–377.
Vasanthan, K. S., Subramanian, A., Krishnan, U. M., & Sethuraman, S. (2012). Role of biomaterials, therapeutic molecules and cells for hepatic tissue engineering. Biotechnology Advances, 30(3), 742–752.
Maguire, T., Davidovich, A. E., Wallenstein, E. J., Novik, E., Sharma, N., Pedersen, H., … Yarmush, M. (2007). Control of hepatic differentiation via cellular aggregation in an alginate microenvironment. Biotechnology and Bioengineering, 98(3), 631–644.
Shi, X. L., Zhang, Y., Gu, J. Y., & Ding, Y. T. (2009). Coencapsulation of hepatocytes with bone marrow mesenchymal stem cells improves hepatocyte-specific functions. Transplantation, 88(10), 1178–1185.
Gattazzo, F., Urciuolo, A., & Bonaldo, P. (2014). Extracellular matrix: A dynamic microenvironment for stem cell niche. Biochimica et Biophysica Acta, 1840(8), 2506–2519.
Vishwakarma, A., & Karp, J. M. (Eds.) (2017). Biology and engineering of stem cell niches. London: Elsevier Academic Press.
Jhala, D., & Vasita, R. (2015). A review on extracellular matrix mimicking strategies for an artificial stem cell niche. Polymer Reviews, 55(4), 561–595.
Scadden, D. T. (2006). The stem-cell niche as an entity of action. Nature, 441(7097), 1075–1079.
Stoker, M., & Gherardi, E. (1991). Regulation of cell movement: The motogenic cytokines. Biochimica et Biophysica Acta, 1072(1), 81–102.
Welf, E. S., & Haugh, J. M. (2011). Signaling pathways that control cell migration: Models and analysis. Wiley Interdisciplinary Reviews: Systems Biology and Medicine, 3(2), 231–240.
Watt, F. M., & Huck, W. T. (2013). Role of the extracellular matrix in regulating stem cell fate. Nature Reviews Molecular Cell Biology, 14(8), 467–473.
Rowley, J. A., & Mooney, D. J. (2002). Alginate type and RGD density control myoblast phenotype. Journal of Biomedical Materials Research, 60(2), 217–223.
Benoit, D. S., Schwartz, M. P., Durney, A. R., & Anseth, K. S. (2008). Small functional groups for controlled differentiation of hydrogel-encapsulated human mesenchymal stem cells. Nature Materials, 7(10), 816–823.
Chokkalingam, V., Tel, J., Wimmers, F., Liu, X., Semenov, S., Thiele, J., … Huck, W. T. (2013). Probing cellular heterogeneity in cytokine-secreting immune cells using droplet-based microfluidics. Lab on a Chip, 13(24), 4740–4744.
Severian Dumitriu, V. P. (2013) Medical and pharmaceutical applications, Vol. 2, 3rd ed. ISBN 978-1-4200-9468-8.
Brandtner, D. (2013). Bioencapsulation of living cells for diverse medical applications. Bentham books. ISBN: 978-1-60805-721-4.
Strand, B. L., Ryan, L., Veld, P. I. T., Kulseng, B., Rokstad, A. M., Skjåk-Bræk, G., & Espevik, T. (2001). Poly-L-Lysine induces fibrosis on alginate microcapsules via the induction of cytokines. Cell Transplant, 10(3), 263–275.
Liu, Z. C., & Chang, T. M. (2002). Increased viability of transplanted hepatocytes when hepatocytes are co-encapsulated with bone marrow stem cells using a novel method. Artificial Cells, Blood Substitutes, and Immobilization Biotechnology, 30(2), 99–112.
Otterlei, M., Østgaard, K., Skjåk-Bræk, G., Smidsrød, O., Soon-Shiong, P., & Espevik, T. (1991). Induction of cytokine production from human monocytes stimulated with alginate. Journal of Immunotherapy, 10(4), 286–291.
Espevik, T., Otterlei, M., Skjåk‐Braek, G., Ryan, L., Wright, S. D., & Sundan, A. (1993). The involvement of CD14 in stimulation of cytokine production by uronic acid polymers. European Journal of Immunology, 23(1), 255–261.
Aiedehe, K., Gianasii, E., Orienti, I., & Zecchi, V. (1997). Chitosan microcapsules as controlled release systems for insulin. Journal of Microencapsulation, 14(5), 567–576.
Altiok, D., Altiok, E., & Tihminlioglu, F. (2010). Physical, antibacterial and antioxidant properties of chitosan films incorporated with thyme oil for potential wound healing applications. Journal of Materials Science. Materials in Medicine, 21(7), 2227–2236.
Green, D. W., Leveque, I., Walsh, D., Howard, D., Yang, X., Partridge, K., … Oreffo, R. O. (2005). Polysaccharide capsules for encapsulation, organization, and delivery of human cell types and growth factors. Advanced Funtional Materials, 15(6), 917–923.
Krasaekoopt, W., Bhandari, B., & Deeth, H. (2004). The influence of coating materials on some properties of alginate beads and survivability of microencapsulated probiotic bacteria. International Dairy Journal, 14(8), 737–743.
Chen, H., Ouyang, W., Jones, M., Metz, T., Martoni, C., Haque, T., … Prakash, S. (2007). Preparation and characterization of novel polymeric microcapsules for live cell encapsulation and therapy. Cell Biochemistry and Biophysics, 47(1), 159–168.
Tan, W., Krishnaraj, R., & Desai, T. A. (2001). Evaluation of nanostructured composite collagen–chitosan matrices for tissue engineering. Tissue Engineering, 7(2), 203–210.
Chevallay, B., & Herbage, D. (2000). Collagen-based biomaterials as 3D scaffold for cell cultures: Applications for tissue engineering and gene therapy. Medical and Biological Engineering and Computing, 38(2), 211–218.
Malafaya, P. B., Silva, G. A., & Reis, R. L. (2007). Natural-origin polymers as carriers and scaffolds for biomolecules and cell delivery in tissue engineering applications. Advanced Drug Delivery Reviews, 59(4–5), 207–233.
Dautzenberg, H., Schuldt, U. T. E., Grasnick, G., Karle, P., MÜller, P., LÖhr, M., … Salmons, B. (1999). Development of cellulose sulfate-based polyelectrolyte complex microcapsules for medical applications. Annals of the New York Academy of Sciences, 875, 46–63.
Swioklo, S., & Connon, C. J. (2016). Keeping cells in their place: The future of stem cell encapsulation. Expert Opinion on Biological Therapy, 16(10), 1181–1183.
Higgins, C. C. (1931). Solitary cysts of the kidney. Annals of Surgery, 93(4), 868–879.
Byass, P. (2014). The global burden of liver disease: A challenge for methods and for public health. BMC Medicine, 12, 159.
Hindley, C. J., Cordero-Espinoza, L., & Huch, M. (2016). Organoids from adult liver and pancreas: Stem cell biology and biomedical utility. Development Biology, 420(2), 251–261.
Fox, I. J., & Chowdhury, J. R. (2004). Hepatocyte transplantation. American Journal of Transplantation, 4(6), 7–13.
Sell, S. (2001). Heterogeneity and plasticity of hepatocyte lineage cells. Hepatology, 33(3), 738–750.
Miyajima, A., Tanaka, M., & Itoh, T. (2014). Stem/progenitor cells in liver development, homeostasis, regeneration, and reprogramming. Cell Stem Cell, 14(5), 561–574.
Itoh (2015). Tissue-specific stem cell niche, stem cell biology and regeneration ed. K. Turksen. Switzerland: Springer.
Conigliaro, A., Brenner, D. A., & Kisseleva, T. (2010). Hepatic progenitors for liver disease: Current position. Stem Cells Cloning, 3, 39–47.
Yang, W., Yan, H. X., Chen, L., Liu, Q., He, Y. Q., Yu, L. X., .… Chen, C. (2008). Wnt/beta-catenin signaling contributes to activation of normal and tumorigenic liver progenitor cells. Cancer Research, 68(11), 4287–4295.
de Lau, W., Barker, N., Low, T. Y., Koo, B. K., Li, V. S., Teunissen, H., … Stange, D. E. (2011). Lgr5 homologues associate with Wnt receptors and mediate R-spondin signalling. Nature, 476(7360). 293–297.
Boulter, L., Govaere, O., Bird, T. G., Radulescu, S., Ramachandran, P., Pellicoro, A., … Sansom, O. J. (2012). Macrophage-derived Wnt opposes notch signaling to specify hepatic progenitor cell fate in chronic liver disease. Nature Medicine, 18(4), 572–579.
Huch, M., Dorrell, C., Boj, S. F., Van Es, J. H., Li, V. S., Van De Wetering, M., … Haft, A. (2013). In vitro expansion of single Lgr5 + liver stem cells induced by Wnt-driven regeneration. Nature, 494(7436), 247–250.
Xinguang, Y., Huixing, Y., Xiaowei, W., Xiaojun, W., & Linghua, Y. (2015). R-spondin1 arguments hepatic fibrogenesis in vivo and in vitro. Journal of Surgical Research, 193(2), 598–605.
Kopp, J. L., Grompe, M., & Sander, M. (2016). Stem cells versus plasticity in liver and pancreas regeneration. Nature Cell Biology, 18(3), 238–245.
Yanger, K., Knigin, D., Zong, Y., Maggs, L., Gu, G., Akiyama, H., … Stanger, B. Z. (2014). Adult hepatocytes are generated by self-duplication rather than stem cell differentiation. Cell Stem Cell, 15(3), 340–349.
Tarlow, B. D., Pelz, C., Naugler, W. E., Wakefield, L., Wilson, E. M., Finegold, M. J., & Grompe, M. (2014). Bipotential adult liver progenitors are derived from chronically injured mature hepatocytes. Cell Stem Cell, 15(5), 605–618.
Ji, J., & Wang, X. W. (2012). Clinical implications of cancer stem cell biology in hepatocellular carcinoma. Seminars in Oncology, 39(4), 461–472.
Di Bonzo, L. V., Ferrero, I., Cravanzola, C., Mareschi, K., Rustichell, D., Novo, E., … Davit, A. (2008). Human mesenchymal stem cells as a two-edged sword in hepatic regenerative medicine: Engraftment and hepatocyte differentiation versus profibrogenic potential. Gut, 57(2), 223–231.
Cai, J., Zhao, Y., Liu, Y., Ye, F., Song, Z., Qin, H., … Guo, Y. (2007). Directed differentiation of human embryonic stem cells into functional hepatic cells. Hepatology, 45(5), 1229–1239.
Basma, H., Soto–Gutiérrez, A., Yannam, G. R., Liu, L., Ito, R., Yamamoto, T., … Muirhead, D. (2009). Differentiation and transplantation of human embryonic stem cell-derived hepatocytes. Gastroenterology, 136(3), 990–999.
Touboul, T., Hannan, N. R., Corbineau, S., Martinez, A., Martinet, C., Branchereau, S., … Weber, A. (2010). Generation of functional hepatocytes from human embryonic stem cells under chemically defined conditions that recapitulate liver development. Hepatology, 51(5), 1754–1765.
Magyar, J. P., Nemir, M., Ehler, E., Suter, N., Perriard, J. C., & Eppenberger, H. M. (2001). Mass production of embryoid bodies in microbeads. Annals of the New York Academy of Sciences, 944(1), 135–143.
Cho, N. J., Elazar, M., Xiong, A., Lee, W., Chiao, E., Baker, J., … Glenn, J. S. (2008). Viral infection of human progenitor and liver-derived cells encapsulated in three-dimensional PEG-based hydrogel. Biomedical materials, 4(1), 011001.
Meier, R. P., Mahou, R., Morel, P., Meyer, J., Montanari, E., Muller, Y. D., … Bühler, L. H. (2015). Microencapsulated human mesenchymal stem cells decrease liver fibrosis in mice. Journal of Hepatology, 62(3), 634–641.
Meier, R. P., Montanari, E., Morel, P., Pimenta, J., Schuurman, H. J., Wandrey, C., … Bühler, L. H. (2017). Microencapsulation of hepatocytes and mesenchymal stem cells for therapeutic applications. Hepatocyte Transplantation: Methods and Protocols, 259–271.
Kisseleva, T., Uchinami, H., Feirt, N., Quintana-Bustamante, O., Segovia, J. C., Schwabe, R. F., & Brenner, D. A. (2006). Bone marrow-derived fibrocytes participate in pathogenesis of liver fibrosis. Journal of hepatology, 45(3), 429–438.
Maguire, T., Novik, E., Schloss, R., & Yarmush, M. (2006). Alginate-PLL microencapsulation: Effect on the differentiation of embryonic stem cells into hepatocytes. Biotechnology and Bioengineering, 93(3). 581–591.
Fang, S., & MAO, L. (2007). Differentiation of embryoid-body cells derived from embryonic stem cells into hepatocytes in alginate microbeads in vitro. Acta Pharmacologica Sinica, 28(12), 1924–1930.
Palakkan, A. A., Hay, D. C., TV, K., & Ross, J. A. (2013). Liver tissue engineering and cell sources: Issues and challenges. Liver International, 33(5), 666–676.
Kirk, K., Hao, E., Lahmy, R., & Itkin-Ansari, P. (2014). Human embryonic stem cell derived islet progenitors mature inside an encapsulation device without evidence of increased biomass or cell escape. Stem Cell Research, 12(3), 807–814.
Scharp, D. W., & Marchetti, P. (2014). Encapsulated islets for diabetes therapy: History, current progress, and critical issues requiring solution. Advanced Drug Delivery Reviews, 67–68, 35–73.
Sakata, N., Sumi, S., Yoshimatsu, G., Goto, M., Egawa, S., & Unno, M. (2012). Encapsulated islets transplantation: Past, present and future. World Journal of Gastrointestinal Pathophysiology, 3(1), 19–26.
Kirchhof, N., Shibata, S., Wijkstrom, M., Kulick, D. M., Salerno, C. T., Clemmings, S. M., … Hering, B. J. (2004). Reversal of diabetes in non-immunosuppressed rhesus macaques by intraportal porcine islet xenografts precedes acute cellular rejection. Xenotransplantation, 11(5), 396–407.
Elliott, R. B., Escobar, L., Tan, P. L. J., Garkavenko, O., Calafiore, R., Basta, P., … Bambra, C. (2005, October). Intraperitoneal alginate-encapsulated neonatal porcine islets in a placebo-controlled study with 16 diabetic cynomolgus primates. Transplantation Proceedings, 37(8), 3505–3508.
Duvivier‐Kali, V. F., Omer, A., Lopez‐Avalos, M. D., O’neil, J. J., & Weir, G. C. (2004). Survival of microencapsulated adult pig islets in mice in spite of an antibody response. American Journal of Transplantation, 4(12), 1991–2000.
Elliott, R. B., Escobar, L., Tan, P. L., Muzina, M., Zwain, S., & Buchanan, C. (2007). Live encapsulated porcine islets from a type 1 diabetic patient 9.5 yr after xenotransplantation. Xenotransplantation, 14(2), 157–161.
Tuch, B. E., Keogh, G. W., Williams, L. J., Wu, W., Foster, J. L., Vaithilingam, V., & Philips, R. (2009). Safety and viability of microencapsulated human islets transplanted into diabetic humans. Diabetes Care, 32(10), 1887–1889.
King, A., Lau, J., Nordin, A., Sandler, S., & Andersson, A. (2003). The effect of capsule composition in the reversal of hyperglycemia in diabetic mice transplanted with microencapsulated allogeneic islets. Diabetes Technology & Therapeutics, 5(4), 653–663.
King, A., Andersson, A., Strand, B. L., Lau, J., Skjåk-Bræk, G., & Sandler, S. (2003). The role of capsule composition and biologic responses in the function of transplanted microencapsulated islets of Langerhans. Transplantation, 76(2), 275–279.
Kulseng, B., Thu, B., Espevik, T., & Skjåk-Bræk, G. (1997). Alginate polylysine microcapsules as immune barrier: Permeability of cytokines and immunoglobulins over the capsule membrane. Cell Transplant, 6(4), 387–394.
Juste, S., Lessard, M., Henley, N., Ménard, M., & Hallé, J. P. (2005). Effect of poly-L-lysine coating on macrophage activation by alginate-based microcapsules: Assessment using a new in vitro method. Journal of Biomedical Materials Research Part A, 72(4), 389–398.
Pueyo, M. E., Darquy, S., Capron, F., & Reach, G. (1994). In vitro activation of human macrophages by alginate-polylysine microcapsules. Journal of Biomaterials Science, Polymer Edition, 5(3), 197–203.
Brennan, D. C., Shannon, M. B., Koch, M. J., Polonsky, K. S., Desai, N., & Shapiro, J. (2004). Portal vein thrombosis complicating islet transplantation in a recipient with the Factor V Leiden mutation. Transplantation, 78(1), 172–173.
Kawahara, T., Kin, T., Kashkoush, S., Gala‐Lopez, B., Bigam, D. L., Kneteman, N. M., … Shapiro, A. J. (2011). Portal vein thrombosis is a potentially preventable complication in clinical islet transplantation. American Journal of Transplantation, 11(12), 2700-2707.
Sakata, N., Tan, A., Chan, N., Obenaus, A., Mace, J., Peverini, R., … Hathout, E. (2009, February). Efficacy comparison between intraportal and subcapsular islet transplants in a murine diabetic model. Transplantation Proceedings, 41(1), 346–349.
Christoffersson, G., Carlsson, P. O., & Phillipson, M. (2011). Intramuscular islet transplantation promotes restored islet vascularity. Islets, 3(2), 69–71.
McQuilling, J. P., Arenas-Herrera, J., Childers, C., Pareta, R. A., Khanna, O., Jiang, B., … Opara, E. C. (2011, November). New alginate microcapsule system for angiogenic protein delivery and immunoisolation of islets for transplantation in the rat omentum pouch. Transplantation Proceedings, 43(9), 3262–3264.
Elliott, R. B., Escobar, L., Calafiore, R., Basta, G., Garkavenko, O., Vasconcellos, A., et al. (2005). Transplantation of micro- and macroencapsulated piglet islets into mice and monkeys. Transplantation Proceedings, 37(1), 466–469.
Dufrane, D., van Steenberghe, M., Goebbels, R. M., Saliez, A., Guiot, Y., & Gianello, P. (2006). The influence of implantation site on the biocompatibility and survival of alginate encapsulated pig islets in rats. Biomaterials, 27(17), 3201–3208.
Algire, G. (1943). An adaptation of the transparent-chamber technique to the mouse. Journal of the National Cancer Institute, 1943(4), 1–11.
Storrs, R., Dorian, R., King, S. R., Lakey, J., & Rilo, H. (2001). Preclinical development of the Islet sheet. Annals of the New York Academy of Sciences, 2001(944), 252–266.
Nyitray, C. E., Chavez, M. G., & Desai, T. A. (2014). Compliant 3D microenvironment improves beta-cell cluster insulin expression through mechanosensing and beta-catenin signaling. Tissue Engineering Part A, 20(13–14), 1888–1895.
de Vos, P., Hamel, A. F., & Tatarkiewicz, K. (2002). Considerations for successful transplantation of encapsulated pancreatic islets. Diabetologia, 45(2), 159–173.
Veriter, S., Aouassar, N., Xhema, D., Beaurin, G., Adnet, P. Y., Igarashi, Y., … Dufrane, D. (2011). Islets and mesenchymal stem cells co-encapsulation can improve subcutaneous bioartificial pancreas survival in diabetic primates. The Transplantation Society: CTS-IXA. Parallel Session 5—ISLET xenotransplantation—Preclinical models.
Davis, N. E., Beenken-Rothkopf, L. N., Mirsoian, A., Kojic, N., Kaplan, D. L., Barron, A. E., & Fontaine, M. J. (2012). Enhanced function of pancreatic islets co-encapsulated with ECM proteins and mesenchymal stromal cells in a silk hydrogel. Biomaterials, 33(28), 6691–6697.
Lee, S. H., Hao, E., Savinov, A. Y., Geron, I., Strongin, A. Y., & Itkin-Ansari, P. (2009). Human beta-cell precursors mature into functional insulin-producing cells in an immunoisolation device: Implications for diabetes cell therapies. Transplantation, 87(7), 983–991.
Matveyenko, A. V., Georgia, S., Bhushan, A., & Butler, P. C. (2010). Inconsistent formation and nonfunction of insulin-positive cells from pancreatic endoderm derived from human embryonic stem cells in athymic nude rats. American Journal of Physiology-Endocrinology and Metabolism, 299(5), E713–E720.
Colton, C. K. (2014). Oxygen supply to encapsulated therapeutic cells. Advanced Drug Delivery Reviews, 67–68, 93–110.
Candiello, J., Singh, S. S., Task, K., Kumta, P. N., & Banerjee, I. (2013). Early differentiation patterning of mouse embryonic stem cells in response to variations in alginate substrate stiffness. Journal of Biological Engineering, 7(1), 9.
Schulz, T. C. (2015). Concise review: Manufacturing of pancreatic endoderm cells for clinical trials in Type 1 diabetes. Stem Cells Translational Medicine, 4(8), 927–931.
Pagliuca, F. W., Millman, J. R., Gürtler, M., Segel, M., Van Dervort, A., Ryu, J. H., … Melton, D. A. (2014). Generation of functional human pancreatic beta cells in vitro. Cell, 159(2), 428–439.
Rezania, A., Bruin, J. E., Arora, P., Rubin, A., Batushansky, I., Asadi, A., … Yang, Y. H. C. (2014). Reversal of diabetes with insulin-producing cells derived in vitro from human pluripotent stem cells. Nature Biotechnology, 32(11), 1121–1133.
Russ, H. A., Parent, A. V., Ringler, J. J., Hennings, T. G., Nair, G. G., Shveygert, M., … Blelloch, R. (2015). Controlled induction of human pancreatic progenitors produces functional beta-like cells in vitro. The EMBO Journal, 34(13), 1759–1772.
Agulnick, A. D., Ambruzs, D. M., Moorman, M. A., Bhoumik, A., Cesario, R. M., Payne, J. K., …Kerr, J. (2015). Insulin-producing endocrine cells differentiated in vitro from human embryonic stem cells function in macroencapsulation devices in vivo. Stem Cells Translational Medicine, 4(10), 1214–1222.
Tateishi, K., He, J., Taranova, O., Liang, G., D’Alessio, A. C., & Zhang, Y. (2008). Generation of insulin-secreting islet-like clusters from human skin fibroblasts. Journal of Biological Chemistry, 283(46), 31601–31607.
Maehr, R., Chen, S., Snitow, M., Ludwig, T., Yagasaki, L., Goland, R., … Melton, D. A. (2009). Generation of pluripotent stem cells from patients with type 1 diabetes. Proceedings of the National Academy of Sciences, 106(37), 15768–15773.
Lysy, P. A., Weir, G. C., & Bonner-Weir, S. (2012). Concise review: pancreas regeneration: Recent advances and perspectives. Stem Cells Translational Medicine, 1(2), 150–159.
Noguchi, H., Xu, G., Matsumoto, S., Kaneto, H., Kobayashi, N., Bonner-Weir, S., & Hayashi, S. (2006). Induction of pancreatic stem/progenitor cells into insulin-producing cells by adenoviral-mediated gene transfer technology. Cell transplantation, 15(10), 929–938.
Alberto Hayek, C.K., Brief review: Cell replacement therapies to treat type 1 diabetes mellitus. Clinical Diabetes and Endocrinology, 2(4).
Mason, M. N., & Mahoney, M. J. (2009). Selective beta-cell differentiation of dissociated embryonic pancreatic precursor cells cultured in synthetic polyethylene glycol hydrogels. Tissue Engineering Part A, 15(6), 1343–1352.
D’Amour, K. A., Bang, A. G., Eliazer, S., Kelly, O. G., Agulnick, A. D., Smart, N. G., … Baetge, E. E. (2006). Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells. Nature Biotechnology, 24(11), 1392–1401.
Kroon, E., Martinson, L. A., Kadoya, K., Bang, A. G., Kelly, O. G., Eliazer, S., … Agulnick, A. D. (2008). Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo. Nature Biotechnology, 26(4), 443–452.
Chen, Y., Pan, F. C., Brandes, N., Afelik, S., Sölter, M., & Pieler, T. (2004). Retinoic acid signaling is essential for pancreas development and promotes endocrine at the expense of exocrine cell differentiation in Xenopus. Developmental Biology, 271(1), 144–160.
Gomes, L. F., Lorente, S., Simon-Giavarotti, K. A., Areco, K. N., Araújo-Peres, C., & Videla, L. A. (2004). Tri-iodothyronine differentially induces Kupffer cell ED1/ED2 subpopulations. Molecular Aspects of Medicine, 25(1–2), 183–190.
Schulz, T. C., Young, H. Y., Agulnick, A. D., Babin, M. J., Baetge, E. E., Bang, A. G., … Kadoya, K. (2012). A scalable system for production of functional pancreatic progenitors from human embryonic stem cells. PLoS One, 7(5), e37004.
Shapiro, A. M., Nanji, S. A., & Lakey, J. R. (2003). Clinical islet transplant: Current and future directions towards tolerance. Immunological Reviews, 196, 219–236.
Wang, T., Lacík, I., Brissová, M., Anilkumar, A. V., Prokop, A., Hunkeler, D., … Powers, A. C. (1997). An encapsulation system for the immunoisolation of pancreatic islets. Nature Biotechnology, 15(4), 358–362.
Desai, T., & Shea, L. D. (2017). Advances in islet encapsulation technologies. Nature Reviews Drug Discovery, 16(5), 367.
Brauker, J. H., Carr‐Brendel, V. E., Martinson, L. A., Crudele, J., Johnston, W. D., & Johnson, R. C. (1995). Neovascularization of synthetic membranes directed by membrane microarchitecture. Journal of Biomedical Materials Research Part A, 29(12), 1517–1524.
Geller, R. L., Loudovaris, T., Neuenfeldt, S., Johnson, R. C., & Brauker, J. H. (1997). Use of an immunoisolation device for cell transplantation and tumor immunotherapy. Annals of the New York Academy of Sciences, 1997(831), 438–451.
Colton, C. K., & Avgoustiniatos, E. S. (1991). Bioengineering in development of the hybrid artificial pancreas. Journal of Biomechanical Engineering, 113(2), 152–170.
Su, J., Hu, B. H., Lowe, W. L., Kaufman, D. B., & Messersmith, P. B. (2010). Anti-inflammatory peptide-functionalized hydrogels for insulin-secreting cell encapsulation. Biomaterials, 31(2), 308–314.
Rafael, E., Wu, G. S., Hultenby, K., Tibell, A., & Wernerson, A. (2003). Improved survival of macroencapsulated islets of Langerhans by preimplantation of the immunoisolating device: A morphometric study. Cell Transplantation, 12(4), 407–412.
Yakhnenko, I., Wong, W. K., Katkov, I. I., & Itkin-Ansari, P. (2012). Cryopreservation of human insulin expressing cells macro-encapsulated in a durable therapeutic immunoisolating device theracyte. Cryo Letters, 33(6), 518–531.
Rafael, E., Wernerson, A., Arner, P., Wu, G. S., & Tibell, A. (1999). In vivo evaluation of glucose permeability of an immunoisolation device intended for islet transplantation: A novel application of the microdialysis technique. Cell Transplantation, 8(3), 317–326.
Kumagai-Braesch, M., Jacobson, S., Mori, H., Jia, X., Takahashi, T., Wernerson, A., … Tibell, A. (2013). The TheraCyte device protects against islet allograft rejection in immunized hosts. Cell Transplantation, 22(7), 1137–1146.
ClinicalTrials.gov/beta/. (2016). ViaCyte: Three Year Follow-up Safety Study in Subjects Previously Implanted With VC-01™.
Acknowledgements
We thank Dr. Kevin D’Amour for providing images from pre-clinical and clinical work at ViaCyte, San Diego, USA.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Hueck, I.S., Frimodig, J., Itkin-Ansari, P., Gough, D.A. (2018). Encapsulation of Stem Cells in Research and Therapy. In: Artmann, G., Artmann, A., Zhubanova, A., Digel, I. (eds) Biological, Physical and Technical Basics of Cell Engineering. Springer, Singapore. https://doi.org/10.1007/978-981-10-7904-7_2
Download citation
DOI: https://doi.org/10.1007/978-981-10-7904-7_2
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-10-7903-0
Online ISBN: 978-981-10-7904-7
eBook Packages: EngineeringEngineering (R0)